The US Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have jointly approved the first-ever product through a parallel review pilot program that seeks to ...
In an expected announcement, the US Food and Drug Administration (FDA) and US Centers of Medicare and Medicaid Services (CMS) have announced they plan to extend and continue a pilot program first ...
Two parallel moves in 24 hours mark a significant escalation of the US-China AI war from chips and exports into capital and models. China plans to restrict its leading technology companies, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results